Preliminary experiments reveal conolidine may perhaps inhibit specific ion channels, minimizing neuronal excitability and limiting suffering alerts. This system is especially applicable in neuropathic soreness, in which abnormal signaling triggers persistent pain. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to discomfort perception. Co... https://kingdomd925igb5.wikiusnews.com/user